{
  "trial_id": "NCT00510640",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Age \u2265 18",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Patients must have a life expectancy of at least 3 months and Karnofsky performance status \u2265 70%",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Patients must have histologically confirmed TC",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Tumor disease must be progressive (evidence of disease progression within 6 months)",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Patients should not be candidates for surgical resection, external beam radiotherapy or radioiodine, and patients must not have more than one previous systemic treatment for cancer",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Patients must have measurable disease defined by RECIST criteria as at least one lesion at least 2 cm in length by conventional CT techniques or at least 1 cm by spiral CT scan.",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Resolution of all acute toxic effects of any prior treatment to NCI - CTCAE (version 3.0) grade < 1.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Patients must have discontinued from radiation therapy at least 4 weeks before first dose of study treatment and must have recovered from any toxic effects of treatment.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Blood pressure < 140 / 90 mmHg",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Patients must have adequate organ function.",
      "label": "met",
      "evidence": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "Prior treatment on sunitinib or other anti-angiogenic therapy",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "NCI CTCAE grade 3 hemorrhage < 4 weeks of starting study treatment",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "History of or known brain metastases, spinal cord compression, or carcinomatous meningitis, or new evidence of brain or leptomeningeal disease",
      "label": "triggers",
      "evidence": "none"
    }
  ],
  "notes": "Patient is a 45-year-old man with a history of anaplastic astrocytoma of the spine complicated by severe lower extremity weakness and urinary retention s/p Foley catheter, high-dose steroids, hypertension, and chronic pain.",
  "_meta": {
    "topic_id": "1",
    "trial_id": "NCT00510640",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_test10_top50"
  }
}